Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT03011814
What this trial is testing

Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

Who this might be right for
Folliculotropic Mycosis FungoidesRecurrent Cutaneous T-Cell Non-Hodgkin LymphomaRecurrent Mycosis Fungoides+5 more
City of Hope Medical Center 78
Not applicableStudy completedNCT03047616
What this trial is testing

A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer

Who this might be right for
Lung Cancer
Abramson Cancer Center at Penn Medicine 88
Large-scale testing (Phase 3)Active Not RecruitingNCT05943106
What this trial is testing

BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants

Who this might be right for
Non-Muscle- Invasive Bladder Cancer
AstraZeneca 100
Very early researchActive Not RecruitingNCT04219904
What this trial is testing

PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer

Who this might be right for
Stage IA Cervical CancerStage IA1 Cervical CancerStage IA2 Cervical Cancer+4 more
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00425204
What this trial is testing

Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

Who this might be right for
Colorectal CancerNon-Small Cell Lung CancerProstate Cancer+2 more
Amgen 31
Large-scale testing (Phase 3)Study completedNCT00917384
What this trial is testing

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma

Who this might be right for
Gastric CancerAdenocarcinoma
Eli Lilly and Company 355
Early research (Phase 1)Study completedNCT00731952
What this trial is testing

Phase I Study of Induction Therapy With VELCADE and Vorinostat in Patients With Surgically Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
University of Virginia 21
Not applicableWithdrawnNCT04345952
What this trial is testing

Calm for Cancer Patients Receiving Chemotherapy

Who this might be right for
Cancer Colorectal
The University of Texas Health Science Center at San Antonio
Testing effectiveness (Phase 2)Ended earlyNCT02314052
What this trial is testing

Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 21
Testing effectiveness (Phase 2)Ended earlyNCT00061958
What this trial is testing

Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the EsophagusStage III Esophageal CancerStage IV Esophageal Cancer
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Looking for participantsNCT06812858
What this trial is testing

PD-1 Inhibitors Maintenance for cHL Post-autoHCT

Who this might be right for
Hodgkin Lymphoma
St. Petersburg State Pavlov Medical University 83
Not applicableApproved For MarketingNCT03089658
What this trial is testing

Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC)

Who this might be right for
Metastatic Merkel Cell Carcinoma
Merck KGaA, Darmstadt, Germany
Large-scale testing (Phase 3)UnknownNCT00002858
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 280
Not applicableLooking for participantsNCT07096258
What this trial is testing

EMPATHY NSCLC: European Registry for Plasma-Based Molecular Profiling in Advanced NSCLC Patients

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Hedera Dx SA 1,000
Testing effectiveness (Phase 2)Study completedNCT02115958
What this trial is testing

The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells Vaccine

Who this might be right for
Neoplasms, Lung
Fuda Cancer Hospital, Guangzhou 40
Testing effectiveness (Phase 2)Study completedNCT00243048
What this trial is testing

Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 70
Testing effectiveness (Phase 2)Study completedNCT00301548
What this trial is testing

Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsCarcinoma
European Institute of Oncology 172
Very early researchLooking for participantsNCT07071155
What this trial is testing

Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia

Who this might be right for
Chronic Myelomonocytic LeukemiaMyelodysplastic SyndromesMyeloproliferative Overlap Neoplasms+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 18
Testing effectiveness (Phase 2)Study completedNCT03486678
What this trial is testing

SHR-1210 in Combination With GEMOX in Patients With Advanced BTC

Who this might be right for
Biliary Tract CancerCholangiocarcinoma
The First Affiliated Hospital with Nanjing Medical University 38
Testing effectiveness (Phase 2)Ended earlyNCT00664378
What this trial is testing

Efficacy Study of CYT997 in Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
Gilead Sciences 5
Next Page